Muralidharan et al. showed that in TERT-promoter mutant glioma (81% IDH-wildtype), this mutation can be detected in 63% of cases in plasma cfDNA employing digital droplet PCR (ddPCR) [89]. This evidence concerns the gene TERT and central nervous system cancer.